# FlowCardia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flowcardia

- Industry: Medical Devices & Equipment
- Headquarters: Sunnyvale, US
- Website: www.flowcardia.com
- Total disclosed funding: $24M
- Latest round: Series C (Sep 11, 2007)
- Investors on record: 10

## About

FlowCardia is a US based medical device company engaged in designs, develops, and manufactures endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization

## Funding rounds

- Series C, Sep 11, 2007, $24M — Frazier Healthcare Partners, EQT Life Sciences, Pappas Capital, Gilde Healthcare, Gold Hill Capital, Panorama Capital, Tekla Capital Management, JP Morgan Asset Management, Rockport Venture Partners, New Science Ventures

## Investors

- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series C
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series C
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series C
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series C
- Gold Hill Capital (https://capitalatlas.ai/funds/gold-hill-capital) — Series C
- Panorama Capital — Series C
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series C
- Rockport Venture Partners — Series C
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series C